<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04978948</url>
  </required_header>
  <id_info>
    <org_study_id>STIMEX - 29BRC21.0025</org_study_id>
    <nct_id>NCT04978948</nct_id>
  </id_info>
  <brief_title>Study of STIM1 Membrane Expression</brief_title>
  <acronym>STIMEX</acronym>
  <official_title>Study of STIM1 Membrane Expression During Autoimmune Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the expression of STIM1 in the plasma membrane of&#xD;
      lymphocytes from patients suffering from different autoimmune diseases in order to identify&#xD;
      new pathologies of interest presenting an over-expression of STIM1PM.&#xD;
&#xD;
      This would allow to initiate, following this study, research and development programs on the&#xD;
      use of anti-STIM1 antibodies in these identified autoimmune diseases of interest.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 11, 2021</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>level of STIM1-PM</measure>
    <time_frame>Day 0</time_frame>
    <description>Membrane expression level of STIM1-PM on the surface of immune cells, measured by flow cytometry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlation between STIM1 expression and Clinical Score</measure>
    <time_frame>Day 0</time_frame>
    <description>Study of correlation between STIM1 expression on different cells and clinical scores of different autoimmune diseases or treatments received</description>
  </secondary_outcome>
  <number_of_groups>14</number_of_groups>
  <enrollment type="Anticipated">430</enrollment>
  <condition>Autoimmune Diseases</condition>
  <arm_group>
    <arm_group_label>Myasthénie</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Myopathie inflammatoire (Myosite)</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Neuropathie autoimmune</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Néphropathies autoimmunes</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hépatite auto-immune</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pancréatite auto-immune</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Purpura Thrombopénique Immunologique</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dermatose bulleuse</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thyroïdite autoimmune</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sclérose en plaque</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sclérose latérale amyotrophique</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Polyarthrite Rhumatoïde</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spondylarthrite axiale</arm_group_label>
    <description>Blood samples will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <description>Patients without autoimune desease* Blood samples will be collected</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      2 venous blood samples/patient&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patient over 18 years old. Diagnosis of one of the autoimmune diseases of interest&#xD;
        according to the commonly accepted classification criteria for each disease, regardless of&#xD;
        the level of disease activity.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of one of the autoimmune diseases&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Treatment with rituximab in the previous 12 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Divi Cornec</last_name>
    <phone>02 98 22 33 33</phone>
    <email>divi.cornec@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Brest - Service de rhumatologie</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Divi CORNEC</last_name>
      <phone>02 98 34 72 64</phone>
      <email>divi.cornec@chu-brest.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 4, 2021</study_first_submitted>
  <study_first_submitted_qc>July 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2021</study_first_posted>
  <last_update_submitted>July 25, 2021</last_update_submitted>
  <last_update_submitted_qc>July 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>autoimmune diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autoimmune Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All collected data that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be available beginning two years and ending five years following the publication</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

